Five Prime Therapeutics, Inc. Defined Contribution Plan, Cost
Five Prime Therapeutics, Inc. reported Defined Contribution Plan, Cost of $712.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-24.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DefinedContributionPlanCostRecognized · last filed 2017-02-24
- Five Prime Therapeutics, Inc. defined contribution plan, cost for the quarter ending 2016-06-30 was $216.00K, a 37.58% increase year-over-year.
- Five Prime Therapeutics, Inc. defined contribution plan, cost for the quarter ending 2016-03-31 was $245.00K, a 36.87% increase year-over-year.
- Five Prime Therapeutics, Inc. defined contribution plan, cost for the quarter ending 2015-12-31 was $47.00K.
- Five Prime Therapeutics, Inc. defined contribution plan, cost for the quarter ending 2015-09-30 was $94.00K.
- Five Prime Therapeutics, Inc. defined contribution plan, cost for fiscal 2016 was $712.00K, a 49.27% increase from fiscal 2015.
- Five Prime Therapeutics, Inc. defined contribution plan, cost for fiscal 2015 was $477.00K.
| Period end | Defined Contribution Plan, Cost 3 month | Defined Contribution Plan, Cost 6 month | Defined Contribution Plan, Cost 9 month | Defined Contribution Plan, Cost 12 month |
|---|---|---|---|---|
| 2016-12-31 | $712.00K 10-K · filed 2017-02-24 | |||
| 2016-06-30 | $216.00K 10-Q · filed 2016-08-05 | $461.00K 10-Q · filed 2016-08-05 | $508.00K derived: sum of 3 quarters · filed 2017-02-24 | $602.00K derived: sum of 4 quarters · filed 2017-02-24 |
| 2016-03-31 | $245.00K 10-Q · filed 2016-05-06 | $292.00K derived: sum of 2 quarters · filed 2017-02-24 | $386.00K derived: sum of 3 quarters · filed 2017-02-24 | $543.00K derived: sum of 4 quarters · filed 2017-02-24 |
| 2015-12-31 | $47.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $141.00K derived: sum of 2 quarters · filed 2017-02-24 | $298.00K derived: sum of 3 quarters · filed 2017-02-24 | $477.00K 10-K · filed 2017-02-24 |
| 2015-09-30 | $94.00K 10-Q · filed 2015-11-05 | $251.00K derived: sum of 2 quarters · filed 2016-08-05 | $430.00K 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $157.00K 10-Q · filed 2016-08-05 | $336.00K 10-Q · filed 2016-08-05 | ||
| 2015-03-31 | $179.00K 10-Q · filed 2016-05-06 |